Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality

Kent W Jones1, A Steven Cain, John H Mitchell

  • 1LDS Hospital and Intermountain Healthcare, Salt Lake City, UT, USA.

Insights

High blood sugar after coronary artery bypass graft (CABG) surgery increases complication risks, including mortality, even without a diabetes mellitus diagnosis. Early postoperative hyperglycemia poses a significant risk, warranting further investigation into glycemic control strategies.

Area of Science:

  • Cardiovascular Surgery
  • Endocrinology
  • Critical Care Medicine

Background:

  • Coronary artery bypass graft (CABG) surgery patients with diabetes mellitus (DM) face higher morbidity and mortality risks.
  • The impact of postoperative hyperglycemia on CABG outcomes, independent of pre-existing DM, requires clarification.

Purpose of the Study:

  • To investigate the association between early postoperative hyperglycemia and adverse outcomes in CABG patients.
  • To determine if high blood glucose levels after surgery independently predict complications, irrespective of a prior DM diagnosis.

Main Methods:

  • A cohort of 2297 CABG patients was analyzed.
  • Postoperative glucose levels (measured 15 minutes after surgery) were used to stratify patients into glycemic groups.
  • Multivariable logistic regression adjusted for Society of Thoracic Surgeons risk scores was employed to assess outcome predictors.

Main Results:

  • Patients with very high postoperative glucose (>200 mg/dl) exhibited significantly higher rates of prolonged ventilation (OR=2.66), extended hospital stay (>14 days, OR=2.06), and mortality (OR=7.71) compared to the normal glucose group.
  • Distribution across glycemic groups: Low (1.9%), Normal (20.7%), High (62.0%), Very High (15.3%).

Conclusions:

  • Blood glucose levels exceeding 200 mg/dl immediately following CABG surgery are linked to increased risks of complications and mortality.
  • Early postoperative hyperglycemia is a significant independent risk factor in CABG patients, underscoring the need for prospective studies on glycemic management.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...